Paroxetine versus nortriptyline in the continuation and maintenance treatment of depression in the elderly
โ Scribed by Gregory M. Bump; Benoit H. Mulsant; Bruce G. Pollock; Sati Mazumdar; Amy E. Begley; Mary Amanda Dew; Charles F. Reynolds III
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 106 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1091-4269
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Depression in the elderly is often not recognised and is frequently under!treated[ Reboxetine is a selective nor! adrenaline reuptake inhibitor "selective NRI# which is e}ective and well tolerated in the treatment of depressed adult patients[ This prospective\ uncontrolled\ multicentre study was des
The authors assessed the severity of nortriptyline's side-effects in older patients with recurrent major depression during placebo-controlled, double-blind maintenance therapy. Data were from 37 patients completing 2-3 years of maintenance therapy; 29 were on nortriptyline and eight were on placebo.
## Objectives: To determine the response to treatment of different subgroups within a sample of physically ill elderly depressed patients. ## Design: Acute geriatric medical inpatients with depression, randomly assigned to an 8-week double-blind placebo-controlled trial of fluoxetine. ## Main ou
Paroxetine improve the quality of sleep and the ease of waking up on subjective measures of sleep (the LSEQ). Dothiepin in contrast improved the ease of getting to sleep, but caused a reduced quality of sleep and a `hangover' eect the next morning.
Objectives. To compare the ecacy of paroxetine and imipramine prospectively in patients with coexisting depression and dementia. Methods. An 8-week, double-blind, parallel group trial comparing paroxetine 20ยฑ40 mg/day with imipramine 50ยฑ100 mg/day in 198 patients aged 60 years or over with a Montgo